| Literature DB >> 26775808 |
Haiyan Ji1, Zhengtao Jiang1, Panpan Lu1, Li Ma2, Chuan Li2, Hanyu Pan1, Zheng Fu1, Xiying Qu1, Pengfei Wang1, Junxiao Deng1, Xinyi Yang1, Jianhua Wang2, Huanzhang Zhu1.
Abstract
HIV-1 escapes antiretroviral agents by integrating into the host DNA and forming a latent transcriptionally silent HIV-1 provirus. Transcriptional activation is prerequisite for reactivation and the eradication of latent HIV-1 proviruses. dCas9-SunTag-VP64 transcriptional system has been reported that it can robustly activate the expression of an endogenous gene using a single guide RNA (sgRNA). Here, we systematically investigated the potential of dCas9-SunTag-VP64 with the designed sgRNAs for reactivating latent HIV-1. We found dCas9-SunTag-VP64 with sgRNA 4 or sgRNA 5 targeted from -164 to -146 or -124 to -106 bp upstream of the transcription start sites of HIV-1 could induce high expression of luciferase reporter gene after screening of sgRNAs targeting different regions of the HIV-1 promoter. Further, we confirmed that dCas9-SunTag-VP64 with sgRNA 4 or sgRNA 5 can effectively reactivate latent HIV-1 transcription in several latently infected human T-cell lines. Moreover, we confirmed that the reactivation of latent HIV-1 by dCas9-SunTag-VP64 with the designed sgRNA occurred through specific binding to the HIV-1 LTR promoter without genotoxicity and global T-cell activation. Taken together, our data demonstrated dCas9-SunTag-VP64 system can effectively and specifically reactivate latent HIV-1 transcription, suggesting that this strategy could offer a novel approach to anti-HIV-1 latency.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26775808 PMCID: PMC4786936 DOI: 10.1038/mt.2016.7
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454